Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07176325 · ClinicalTrials.gov registry record
Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation
A clinical trial of Side Effects of Creatine Monohydrate Dosing, sponsored by Vireo Systems.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT07176325: Completed study of Side Effects of Creatine Monohydrate Dosing, sponsored by Vireo Systems.
NCT07176325 is a study of Side Effects of Creatine Monohydrate Dosing that has completed, run by Vireo Systems. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07176325, a study of Side Effects of Creatine Monohydrate Dosing, has completed, sponsored by Vireo Systems.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aimed to investigate the incidence and severity of GI symptoms associated with daily CM supplementation, with and without a loading phase, in healthy male and female adults.
Primary Outcome
Gastrointestinal effects are well known, particularly at higher doses.
Conditions Studied
Interventions
- OTHER Creatine Monohydrate
Study Locations (1)
New Jersey
- Princeton Consumer Research - Raritan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2024-07-03 |
What the finished NCT07176325 record still lists
NCT07176325 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 1 condition, with Side Effects of Creatine Monohydrate Dosing appearing as the primary indexed condition, and to 1 intervention - of which Creatine Monohydrate is the first listed.
NCT07176325 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07176325 about?
NCT07176325 is a clinical study titled "Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation". This study aimed to investigate the incidence and severity of GI symptoms associated with daily CM supplementation, with and without a loading phase, in healthy male and female adults.
What is the current status of trial NCT07176325?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2024-05-30. Estimated completion is 2024-07-03.
What conditions does trial NCT07176325 study?
This clinical trial studies the following conditions: Side Effects of Creatine Monohydrate Dosing.
What interventions are being tested in trial NCT07176325?
The interventions under investigation include: Creatine Monohydrate (OTHER).
Who is sponsoring clinical trial NCT07176325?
This trial is sponsored by Vireo Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07176325 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI